Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and metformin both help treat PCOS, but using them together works best.

PCOS may increase the risk of certain cancers.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

A young Saudi girl with uncontrolled type 1 diabetes and hypothyroidism had two rare conditions, Mauriac syndrome and Van Wyk–Grumbach syndrome.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

PRP therapy may effectively treat hair loss, but more research needed.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Cells treated with Wnt-10b can grow hair after being transplanted into mice.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

Understanding hair biology is key to developing better treatments for hair and scalp issues.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Activin B helps start and grow hair follicles in mice.